They decrease the inhibitory effects of cholinergics on dopamine signalling.

They restore the balance between dopamine signalling and unopposed cholinergic activity that occurs in Parkinson's disease.

Their action is largely restricted to the periphery.

They can be used to control the nausea associated with D2 receptor agonists used to treat Parkinson's.